0:00
/

HealthTech 101: Strategic VC Insights to Approach the Healthcare Industry | Deep Tech Catalyst

Andrew Rubenstein, founding partner at Shorewind Capital, on how HealthTech founders navigate regulation, go-to-market strategy, distribution, and the investor landscape.

👋 Welcome to the 53rd edition of Deep Tech Catalyst, the channel by The Scenarionist where science meets venture!

Products and companies may straddle the boundaries between HealthTech and MedTech, creating a gray area. However, understanding this distinction is crucial when planning the regulatory path, go-to-market strategy, distribution, and ultimately, the type of VC funds involved.

In this episode, we are thrilled to welcome Andrew Rubenstein, Founding Partner at Shorewind Capital. He will help us to pinpoint what makes these two paths different, highlight best practices for HealthTech go-to-market strategies and distribution tactics, and explain how to avoid the most common pitfalls in the early stages.


Key Themes Covered:

  • 🏥 Understanding The Line Between HealthTech and MedTech

  • 🩻 Emerging Trends: Preventive Care and AI

  • ⛔️ A Common Pitfall: Shifting from Consumer to Traditional Healthcare

  • 🤝 Core Team Skillset in HealthTech vs MedTech

  • 🚀 3 Distribution and Go-to-Market Strategies in HealthTech

  • ⏱️ Timelines and VC Expectations in HealthTech vs. MedTech Startups


BEYOND THE CONVERSATION — STRATEGIC INSIGHTS FROM THE EPISODE

Keep reading. It’s free.

Join The Scenarionist community to unlock the full episode notes and key takeaways. Subscribe for free to continue reading.


Disclaimer
All materials published by The Scenarionist are provided solely for informational and educational purposes. They do not constitute financial, legal, or tax advice, nor do they constitute a recommendation, offer, or solicitation to buy or sell securities, crypto assets, or any other assets. The Scenarionist strives to provide accurate information but does not guarantee that its materials are complete, current, or free from errors, and assumes no liability for any reliance placed on them. Any external partnership or sponsored content will be clearly identified as “Brought to you by.” Unless otherwise disclosed, the companies and technologies mentioned do not sponsor The Scenarionist and are not included in its investment holdings. Artificial intelligence tools may be used for operational support and content refinement.

Ready for more?